Lee Financial’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Lee Financial’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-81,362	Closed	-$250K	–	168
2026 Q1	$250K	Hold	81,362	–	–	0.04%	135
2025 Q4	$290K	Hold	81,362	–	–	0.04%	119
2025 Q3	$284K	Hold	81,362	–	–	0.04%	154
2025 Q2	$167K	Hold	81,362	–	–	0.02%	142
2025 Q1	$92.8K	Hold	81,362	–	–	0.01%	141
2024 Q4	$25.1K	Hold	81,362	–	–	﹤0.01%	181
2024 Q3	$26.6K	Buy	81,362 +53,382	+191%	+$22.1K	﹤0.01%	182
2024 Q2	$12.9K	Hold	27,980	–	–	﹤0.01%	147
2024 Q1	$44.2K	Buy	+27,980	New	+$53.2K	0.01%	143

Other funds holding STLN

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

KWA

Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

T3 Companies New York $93.7M AUM

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

IAAG

Innovative Asset Advisors Group Shelton, Connecticut $229M AUM

Lee Financial's STLN Position: Q2 2026 in Review

Lee Financial sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q2 2026, closing a stake of 81,362 shares — an estimated $250K sold.

Lee Financial first reported a position in STLN in Q1 2024 and held it in 9 quarters. The position peaked at $290K in Q4 2025. 29 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

Lee Financial reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q2 2026 after selling out during the quarter.
Lee Financial sold 81,362 Starling Oncology Institute, Inc. Common Stock shares in Q2 2026, an estimated $250K.
Lee Financial first reported a position in Starling Oncology Institute, Inc. Common Stock in Q1 2024 and held it in 9 quarters.
Lee Financial's Starling Oncology Institute, Inc. Common Stock position peaked at $290K in Q4 2025.
29 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2026.

Based on Lee Financial's 13F filing for Q2 2026, filed 22 Jul 2026.